01/27/2022
Get your Tollovid at Hempori.com
https://investor.todosmedical.com/news-events/press-releases/detail/177/todos-medical-and-nlc-pharma-announce-primary-and-secondary
Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 Patients January 27, 2022 8:23am EST Download as PDF § Phase 2 Study NLC-V-01 closed early afte...